CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
PGX Technology
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGX
Stock Information CZO
TSX Venture
CZO
Change
Volume
Day Range
52 Week Range
Stock Information CRPOF
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Corporate Presentation
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View Presentation
Products
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Latest News
Ceapro Inc. Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate Update
Aug 24, 2022 | Read More
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis
Aug 11, 2022 | Read More
Ceapro Inc. Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids
Aug 9, 2022 | Read More
Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer
Jul 12, 2022 | Read More